Robuta

https://www.benzinga.com/quote/ALNY/news Latest Alnylam Pharmaceuticals Stock News | NASDAQ:ALNY | Benzinga Get the latest news on Alnylam Pharmaceuticals stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on ALNY performance alnylam pharmaceuticalsstock newslatestnasdaqbenzinga https://ipverse.greyb.com/litigations/alnylam-pharmaceuticals-inc-v-moderna-inc--ded--1-23-cv-00580 Alnylam Pharmaceuticals, Inc. V. Moderna, Inc. - 1:23-cv-00580 - IP Verse Alnylam Pharmaceuticals, Inc. V. Moderna, Inc. (Case No. 1:23-cv-00580), filed on May 26, 2023 in the District Court, D. Delaware involving patent... alnylam pharmaceuticals incvmodernaip https://informaconnect.com/asia-tides/speakers/muthiah-mano-manoharan-phd/ Muthiah (Mano) Manoharan, PhD - Alnylam Pharmaceuticals | TIDES Asia: Oligonucleotide & Peptide... Informa Connect's TIDES Asia is the only event in Asia bringing together science, technologies and partners to accelerate oligonucleotide and peptide molecules... alnylam pharmaceuticalsmanophdtidesasia https://www.etfchannel.com/symbol/alny/ ETFs Holding ALNY | Alnylam Pharmaceuticals Inc ETF Exposure and Holdings See which ETFs hold ALNY, Alnylam Pharmaceuticals Inc, and compare ALNY exposure by fund weight, total amount held, and number of ETFs containing the stock. alnylam pharmaceuticals incetfsholdingexposure https://careers.ispe-casa.org/jobs/21935235/alnylam-pharmaceuticals-us-medical-affairs-postdoctoral-research-fellow Alnylam Pharmaceuticals-US Medical Affairs Postdoctoral Research Fellow in Boston, MA for... Exciting opportunity in Boston, MA for Northeastern University as a Alnylam Pharmaceuticals-US Medical Affairs Postdoctoral Research Fellow postdoctoral research fellowalnylam pharmaceuticalsus medicalin bostonaffairs https://topworkplaces.com/company/alnylam-pharmaceuticals/boston/ Working at Alnylam Pharmaceuticals, Inc. | Top Workplaces working at alnylamtop workplacespharmaceuticalsinc https://investors.alnylam.com/press-release?id=28546 Alnylam Pharmaceuticals Press Release | Nov 25, 2024 | Alnylam Announces U.S. Food and Drug... Alnylam Announces U.S. Food and Drug Administration Acceptance of Supplemental New Drug Application for Vutrisiran for the Treatment of ATTR Amyloidosis with... food and drugalnylam pharmaceuticalspress releasenovannounces https://www.macrotrends.net/stocks/charts/ALNY/alnylam-pharmaceuticals/price-fcf Alnylam Pharmaceuticals Price to Free Cash Flow Ratio 2012-2026 | ALNY | MacroTrends Historical price to free cash flow ratio values for Alnylam Pharmaceuticals (ALNY) since 2012. free cash flowalnylam pharmaceuticalspriceratiomacrotrends https://www.tigertrade.app/earnseason/ALNY Alnylam Pharmaceuticals (ALNY) Earnings Calendar_Earnings Analysis_Financial Report and Earnings... A top trading platform from a NASDAQ listed company enables investors to invest in the global giants from only USD 1, and here you can access to investment... alnylam pharmaceuticalsearnings calendarfinancial reportanalysis https://multiples.vc/public-comps/alnylam-pharmaceuticals-valuation-multiples Alnylam Pharmaceuticals - Multiples.vc - Public Comps and Valuation Multiples As of May 2026, Alnylam Pharmaceuticals has a market cap of $39B, revenue of $4B, revenue valuation multiple of 8.5x, and EBITDA valuation multiple of 40.4x. alnylam pharmaceuticalspublic compsmultiplesvcvaluation https://tickeron.com/ticker/ALNY/forecasts-predictions/ Alnylam Pharmaceuticals (ALNY) Stock Forecast: RNAi Pipeline Momentum and 2026 Revenue Catalysts Alnylam maintains leadership in RNA interference (RNAi) therapeutics, holding over 90% global market share with four approved drugs targeting rare diseases. Q1... alnylam pharmaceuticalsstock forecastrnaipipelinemomentum https://www.financialcontent.com/quote/NQ:ALNY/chart Stock Chart for Alnylam Pharmaceuticals, Inc. - Common Stock (Nasdaq:ALNY) | FinancialContent View a technical stock chart for Alnylam Pharmaceuticals, Inc. - Common Stock (Nasdaq:ALNY) alnylam pharmaceuticals incstock chartcommonnasdaq https://uk.marketscreener.com/quote/stock/ALNYLAM-PHARMACEUTICALS-I-8322/news/UBS-Raises-Alnylam-Pharmaceuticals-Price-Target-to-308-From-288-Buy-Rating-Maintained-47684882/ UBS Raises Alnylam Pharmaceuticals' Price Target to $308 From $288, Buy Rating Maintained |... Aug 19, 2024 - Alnylam Pharmaceuticals has an average outperform rating and price target range of $160.50 to $400, according to analysts polled by Capital IQ. Price: 273.15,... alnylam pharmaceuticalsprice targetubsbuyrating https://www.illumina.com/company/news-center/press-releases/2025/65116392-fb5c-4513-a1fe-b36f8f8a4ea5.html Alnylam Pharmaceuticals joins Alliance for Genomic Discovery, expanding diverse clinical genomic... Alnylam Pharmaceuticals joins Alliance for Genomic Discovery, expanding diverse clinical genomic dataset to drive precision medicine alnylam pharmaceuticalsjoinsalliancegenomicdiscovery https://ayafintech.network/stock-ratio/ALNY/ Alnylam Pharmaceuticals Inc. Common Stock (ALNY) Key financial ratios - real-time stock prices,... Alnylam Pharmaceuticals Inc. Common Stock (ALNY) AYA fintech network platform provides proprietary alpha stock signals, CAPM alphas, Fama-French alphas,... alnylam pharmaceuticals inckey financial ratiosreal time pricescommon stock https://www.webull.com/news/13443802147438592 Where Alnylam Pharmaceuticals Stands With Analysts alnylam pharmaceuticalsstandsanalysts https://www.cmlviz.com/stocks/ALNY/news/2022/07/26/custom-pre-earnings-bullish-diagonal-trigger-in-alnylam-pharmaceuticals-inc Custom Pre-earnings Bullish Diagonal Trigger in Alnylam Pharmaceuticals Inc Jul 26, 2022 - Custom Pre-earnings Bullish Diagonal Trigger in Alnylam Pharmaceuticals Inc (NASDAQ:ALNY) Earnings. alnylam pharmaceuticals inccustompreearningsbullish https://www.stockconsultant.com/consultnow/basicplus.cgi?symbol=ALNY ALNY Stock Charts, Analysis, Trend, Alnylam Pharmaceuticals Inc ALNY, Alnylam Pharmaceuticals Inc stock technical analysis with charts, breakout and price targets, support and resistance levels, and more trend analysis... alnylam pharmaceuticals incstock chartsanalysistrend https://companiesmarketcap.com/alnylam-pharmaceuticals/cost-to-borrow/ Alnylam Pharmaceuticals (ALNY) - Cost to borrow List of the companies with highest cost to borrow on Interactive Brokers. The cost to borrow is in annualized percents. alnylam pharmaceuticalscostborrow https://stocks-assistant.kreatebots.com/alnylam-pharmaceuticals-inc/2026/q1/chat ALNYLAM-PHARMACEUTICALS-INC Assistant - 2026 Q1 | Stocks Assistant Get detailed insights about ALNYLAM-PHARMACEUTICALS-INC for Q1 of 2026. alnylam pharmaceuticals incassistantstocks https://bulios.com/ticker/DUL.DE Alnylam Pharmaceuticals, Inc. (DUL.DE) Stock | DUL.DE Stock Price & Analysis - Bulios Get the latest news and market analysis for Alnylam Pharmaceuticals, Inc. (DUL.DE). Stay up-to-date on DUL.DE Stock price and share price with Bulios. Explore... alnylam pharmaceuticals incstock priceduldeanalysis https://pro.kraken.com/app/trade/stocks-alny ALNY (Alnylam Pharmaceuticals) - Trade Stocks | Kraken Pro Trade Alnylam Pharmaceuticals (ALNY) on Kraken Pro. Trade stocks alongside crypto with real-time pricing, professional execution, and multi-asset portfolio... alnylam pharmaceuticalstrade stockskraken pro https://www.europharmajobs.com/job_display/281592/Associate_Director_Clinical_Pharmacology_Alnylam_Pharmaceuticals_Maidenhead_Zug_or_Amsterdam_Multiple_Countries Associate Director, Clinical Pharmacology - Alnylam Pharmaceuticals, Maidenhead, Zug or Amsterdam Apply for the Associate Director, Clinical Pharmacology Job, Alnylam Pharmaceuticals, Maidenhead, Zug or Amsterdam, Multiple Countries. Pharma Jobs in Europe... associate directorclinical pharmacologyalnylam pharmaceuticalsmaidenheadzug https://www.ariva.de/aktien/alnylam-pharmaceuticals-inc-aktie/news Alnylam Pharmaceuticals Aktie Nachrichten Alle Nachrichten zur Alnylam Pharmaceuticals Aktie - aktuelle News, Analysen und Unternehmensmeldungen auf einen Blick. alnylam pharmaceuticalsaktienachrichten https://www.biospace.com/alnylam-pharmaceuticals-initiates-phase-i-clinical-study-of-aln-rsv01-an-rnai-therapeutic-for-the-treatment-of-respiratory-syncytial-virus-rsv-infe Alnylam Pharmaceuticals Initiates Phase I Clinical Study Of ALN-RSV01, An RNAi Therapeutic For The... alnylam pharmaceuticalsclinical studyfor thephasernai https://www.dcatvci.org/features/pharma-company-on-the-move-alnylam-pharmaceuticals/ Pharma Company on the Move: Alnylam Pharmaceuticals - DCAT Value Chain Insights Sep 13, 2021 - Buoyed by $2 billion in funding by the private equity firm, Blackstone, a $1-billion partnering deal with Regeneron Pharmaceuticals, and potential gains from a... on the movepharma companyalnylam pharmaceuticalsvalue chaindcat https://www.realchemistry.com/embracing-the-power-of-rnai-therapeutics/ Embracing the Power of RNAi Therapeutics: Akshay Vaishnaw, Alnylam Pharmaceuticals - Real Chemistry Oct 24, 2025 - Real Chemistry is AI and ideas coming together. We are an end-to-end healthcare experience group designed to help brands and people reach their potential. the power ofalnylam pharmaceuticalsreal chemistryembracingrnai https://www.alnylam.jp/ Alnylam® Pharmaceuticals | Alnylam Japan pharmaceuticalsjapan https://www.alnylam.de/ Alnylam® Pharmaceuticals | Deutschland | Alnylam-de pharmaceuticalsdeutschland